Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs.
Citation
Fischer MA, Polinski JM, Servi AD, et al. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum 2008 Nov 15;59(11):1611-7.
Principal Investigator
Document Type
Research Method